Hemodialysis patients are at high risk for acquiring bloodborne infections. The dialysis treatment requires large volumes of blood to be processed outside of the body. Contact either directly or indirectly with the contaminated environment, equipment, or hands of healthcare workers (HCWs) may result in the transmission of blood-borne pathogens [1] .
Hepatitis B virus (HBV) is spread by percutaneous or permucosal exposure to blood or body fluids that contain HBV. HBV is relatively stable in the environment and can remain viable for at least seven days on environmental surfaces [1, 5] . Hemodialysis programs should institute a comprehensive HBV prevention plan [1, 4] , including the recommendations provided below, and audits [6] . These recommendations address the prevention and management of HBV infection in hemodialysis patients. Other blood-borne pathogens (such as hepatitis C or HIV) do not require isolation. These patients are effectively managed through the implementation of routine practices [1] [2] [3] [4] . • Staff: HBV immunization of HCWs began in Canada in 1982 and is recommended for those persons at increased risk of occupational infection (i.e., those exposed to blood, blood products, and bodily fluids that may contain the virus) [2, 4, 5] . Hemodialysis programs should have a policy and procedures to monitor HCWs' HBV immunization. • Test all who have been vaccinated for antibody to hepatitis B surface antigen (anti-HBs) one to two months after the last primary vaccine dose in order to determine their response to the vaccine (adequate response is defined as > 10 mIU/mL) [2, 4, 5] . Patients and staff members who do not respond to the primary vaccine series should be revaccinated with three additional doses and retested for response. No additional doses of the vaccine are warranted for those who do not respond to the second series [2, 4] . In this case, follow recommendations for patients considered susceptible.
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Containment and management
Contact transmission is the most important route by which pathogens are transmitted in healthcare settings [3] .
• Consistently use routine practices for the care of all hemodialysis patients [3] . • Hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection to patients and staff [ [1, 4] . • HBV-immune patients may act as a geographical buffer between positive and susceptible patients [1, 4] . • Staff members can be assigned to care for both HBVpositive and HBV-immune patients on the same shift. There must be current serology to confirm the patient's HBV immunity prior to assigning the two groups together. Protection against HBV is not maintained if the patient's anti-HBs drop below protective levels of 10 mlU/ml [1, 4] .
Cleaning and disinfection
• The internal surface (previously, "pathways") of the dialysis machine used on an HBV-positive patient must be disinfected with a high-level disinfectant prior to use on another patient [1, 4] . • The external surface of the dialysis machine must be cleaned and disinfected with a facility-approved lowlevel disinfectant prior to use on another patient [1, 4] . • Following dialysis treatment, clean and disinfect all surfaces in the dialysis station with a facility-approved disinfectant, including the bed/chair, table, doorknobs, and television remote [1, 4] . • For centres with dialyzer reprocessing programs, dialyzers should not be reused on HBsAg-positive patients [1] .
Screening
• Serologic testing of all chronic kidney disease patients should occur prior to admission to the program or at the first dialysis treatment (hemodialysis or peritoneal dialysis). This should include testing for HBsAg, anti-HBs, and hepatitis B core antibody [4] . • If the patient's HBV status is unknown at the time of first treatment, the dialysis machine must not be used on another patient until the internal and external surfaces have been cleaned and disinfected [4] . • A method should be developed to monitor, review, evaluate, and communicate all serological testing for HBV [1, 4] . • Annual testing of all hemodialysis patients is required to determine immunity, susceptibility, and/or conversion. Susceptible patients should be tested more frequently until immunity has been established by vaccination. The frequency of testing (Q monthly, Q two months, or Q six months) will depend on the patient population and risk [1, 4] .
• Programs should have a policy for follow-up and testing of susceptible patients who have received hemodialysis at other facilities (e.g., while travelling). 
Education
GLOSSARY/DEFINITIONS
As per the Canadian Standard Association: "SHALL" is used to express a requirement, i.e., a provision that the user is obliged to satisfy in order to comply with the standard;
"SHOULD" is used to express a recommendation or that which is advised but not required; and "MAY" is used to express an option or that which is permissible within the limits of the standard, an advisory or optional statement.
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